Day One Biopharmaceuticals, Inc. (DAWN)

NASDAQ: DAWN · Real-Time Price · USD

13.31

-1.01 (-7.05%)

At close: Nov 15, 2024, 4:00 PM

13.50

+0.19 (1.43%)

After-hours: Nov 15, 2024, 5:40 PM EST

DAWN Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-84.29	-188.92	-142.18	-70.65	-40.51	-12.63
Depreciation & Amortization	1.37	0.38	0.53	0.2	0.16	-
Asset Writedown & Restructuring Costs	55	3	-	8	-	-
Loss (Gain) From Sale of Investments	-5.14	-10.08	-2.03	-	-	-
Stock-Based Compensation	48.04	39.34	27.24	13.32	0.53	0.11
Other Operating Activities	-108	-	-	-2.11	26.69	7.56
Change in Accounts Payable	-0.37	2.32	-1.48	1.54	0.13	0.01
Change in Other Net Operating Assets	10.78	7.1	8.05	1.15	-0.49	0.43
Operating Cash Flow	-89.48	-146.85	-109.87	-48.54	-13.49	-4.52
Capital Expenditures	-0.76	-0.22	-0.03	-	-0.09	-
Sale (Purchase) of Intangibles	-72.1	-3	-	-8	-	-
Investment in Securities	33.88	131.6	-255.05	-	-	-
Investing Cash Flow	69.03	128.38	-255.07	-8	-0.09	-
Long-Term Debt Issued	-	-	-	-	-	1
Net Debt Issued (Repaid)	-	-	-	-	-	1
Issuance of Common Stock	181.1	164	165.9	167.36	-	-
Financing Cash Flow	202.04	164	165.9	297.12	29.98	30.91
Net Cash Flow	181.59	145.52	-199.05	240.58	16.4	26.39
Free Cash Flow	-90.24	-147.08	-109.9	-48.54	-13.58	-4.52
Free Cash Flow Per Share	-1.01	-1.84	-1.68	-1.31	-2.46	-0.76
Levered Free Cash Flow	-151.71	-82.72	-56.86	-37.01	-9.6	-
Unlevered Free Cash Flow	-151.71	-82.72	-56.86	-37.01	-9.58	-
Change in Net Working Capital	-0.77	-9.57	-7.21	-2.94	1.56	-

Source: S&P Capital IQ. Standard template. Financial Sources.